文献速递疝与腹壁外科围术期管理与 ERAS

机器人对比腹腔镜腹腔内补片腹壁疝修补术:PROVE-IT随机临床试验1年探索性结局

Robotic vs Laparoscopic Ventral Hernia Repair with Intraperitoneal Mesh: 1-Year Exploratory Outcomes of the PROVE-IT Randomized Clinical Trial.
PubMed 文献 · J Am Coll Surg · 2022-03-14

PROVE-IT随机临床试验比较腹腔镜与机器人腹腔内补片腹壁疝修补术,1年随访率95%(71/75),中位随访12个月。校正基线后,两组术后1年疼痛强度无差异(p=0.94);机器人组HerQLes评分较腹腔镜组多增加12.0分(95%CI 1.3-22.7,p=0.03),但复合疝复发率机器人组24%(9/38)高于腹腔镜组6%(2/33)(p=0.04),再手术率无差异(p=0.61)。

要点

  • 机器人组1年疝特异性生活质量评分改善优于腹腔镜组。
  • 机器人组复合疝复发率24%高于腹腔镜组6%。
  • 两组1年疼痛强度和再手术率无差异。

核心结论

  • 探索性分析发现生活质量和复发率可能存在差异,分别利于机器人和腹腔镜入路,需更大样本验证。

研究设计与样本

  • 基于注册的随机临床试验,纳入腹腔镜或机器人腹腔内补片腹壁疝修补术患者,1年随访率95%(71/75),其中腹腔镜33例、机器人38例,中位随访12个月(IQR 10-12)。

主要发现

  • 校正基线评分后,术后1年疼痛强度无差异(p=0.94)。
  • 机器人组HerQLes评分较腹腔镜组多增加12.0分(95%CI 1.3-22.7,p=0.03)。
  • 复合疝复发率腹腔镜组6%(2/33),机器人组24%(9/38)(p=0.04)。
  • 再手术率无差异(p=0.61)。

临床怎么用

  • 机器人腹壁疝修补可能改善1年疝特异性生活质量,但需警惕复发风险。
  • 腹腔镜腹壁疝修补1年复发率较低,可作为术式选择参考。
  • 术式选择应结合生活质量获益与复发风险个体化决策。

局限性

  • 探索性次要结局,样本量小(71例),随访时间短(中位12个月),需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic and robotic ventral hernia repair with intraperitoneal mesh have been demonstrated previously to have comparable 30-day outcomes in the PROVE-IT randomized clinical trial. Here we report our 1-year follow-up of enrolled patients to examine exploratory outcomes. STUDY DESIGN: All patients enrolled in a previously published, registry-based, randomized trial investigating laparoscopic vs robotic ventral hernia repair with intraperitoneal mesh were reviewed. Several exploratory secondary outcomes were assessed: pain intensity (Patient-Reported Outcomes Measurement Information System [PROMIS 3a]), hernia-specific quality of life (Hernia-Specific Quality of Life Survey [HerQLes]), composite hernia recurrence, and reoperations. RESULTS: A total of 95% (71 of 75) follow-up was achieved: 33 laparoscopic repairs and 38 robotic repairs. Median follow-up time was 12 months [interquartile range 10 to 12 months]. Following regression analysis adjusting for baseline scores, there was no difference in postoperative pain intensity at 1 year (p = 0.94). However, HerQLes scores increased by 12.0 more points following robotic repairs compared to laparoscopic counterparts (95% CI 1.3 to 22.7, p = 0.03). Composite hernia recurrence was 6% (2 of 33) for the laparoscopic cohort and 24% (9 of 38) for the robotic group (p = 0.04). There was no difference in rates of reoperation (p = 0.61). CONCLUSIONS: Our exploratory analyses have identified potential differences in quality of life and recurrence, favoring the robotic and laparoscopic approaches, respectively. These findings warrant further study with larger patient cohorts to verify their potential significance.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Petro CC, Thomas JD, Tu C, et al. Robotic vs Laparoscopic Ventral Hernia Repair with Intraperitoneal Mesh: 1-Year Exploratory Outcomes of the PROVE-IT Randomized Clinical Trial. J Am Coll Surg. 2022. PMID: 35703814. doi:10.1097/XCS.0000000000000171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。